SSI Strategy

The Emerging Biotech Leader

Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: ssistrategy.com

Autor

SSI Strategy

Kategoria

Business

Strona podcastu

ssistrategy.com

Ostatni odcinek

9 lip 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android 5 mln+ pobrań · ocena 4,8 iOS niedługo

Odcinki

Flexible Leadership in Biotech: Building Teams Around Program Needs 09.07.2026

Chris Kennedy, CEO of Pacific Genetech, examines a different approach to building leadership teams in early-stage biotech: building organizations around program needs rather than fixed leadership structures. 

Designing Studies that Work in Complex Settings 22.05.2026

Brendan Slagle, Senior Director, Medical at SSI Strategy discusses why operational feasibility needs to be built into study design from the beginning rather than addressed later during execution. 

Rethinking Trial Design for Rare Diseases 08.05.2026

Marshall Summar, CEO & Founder of Uncommon Cures, discusses why many conventional trial models break down in rare disease settings, and what stronger alternatives look like in practice.

Driving Global Patient Access: Managed Access as a Strategic Lever 05.02.2026

Nicky Wisener explores how emerging biotechs can think more strategically about patient access well before commercialization. 

Rare Disease Commercialization: Beyond Approval 14.01.2026

Matt Trudeau discusses what it means to operate within a family-run pharmaceutical company and how that model shapes decision-making differently than a public or venture-backed organization.  

Clinical Operations as a Strategic Function 05.12.2025

Meaghan Powers, Senior Director of Clinical Operations at SSI Strategy, offers a clear view of where clinical operations drives strategic value and how early engagement can set emerging biotechs up for success.

How Clinical Operations Shapes Biotech Strategy 21.11.2025

Sharon Arnold, a seasoned clinical operations executive with more than two decades of experience in both large pharma and emerging biotechs, speaks about how operational leadership determines whether innovation reaches the clinic successfully. 

50 Episodes in: Lessons from The Emerging Biotech Leader 10.11.2025

Podcast hosts, Kim Kushner and Ramin Farhood celebrate the anniversary of The Emerging Biotech Leader, marking three years, 50 episodes, and listeners across 50 countries.

Biotech Leadership: The CEO–CMO Dynamic 07.11.2025

Adriana Valenciano, Senior Vice President at SSI Strategy, takes a closer look at how leadership partnerships, the structure of a Target Product Profile, and the intentional use of AI all shape how young organizations grow. 

From TPP to Teamwork: Creating Structure as a Biotech CMO 10.10.2025

Dr. Ed Tucker talks about what he’s learned after serving as CMO in large pharma and startups.

Słuchaj podcastu The Emerging Biotech Leader w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS